Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)

IND for One Patient to Receive Clofazamine for Treatment of MAI

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00652067

Enrollment

Registered

2008-04-03

Start date

2006-05-31

Completion date

2007-05-31

Last updated

2008-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Mycobacterium Avium-Intracellulare

Keywords

Mycobacterium avium-intracellulare

Brief summary

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

Interventions

None listed

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Treatment of one patient with MAI

Exclusion criteria

* No other patients will be treated

Outcome results